Does ROSUVASTATIN Cause Pericardial effusion? 172 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 172 reports of Pericardial effusion have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.5% of all adverse event reports for ROSUVASTATIN.
172
Reports of Pericardial effusion with ROSUVASTATIN
0.5%
of all ROSUVASTATIN reports
3
Deaths
167
Hospitalizations
How Dangerous Is Pericardial effusion From ROSUVASTATIN?
Of the 172 reports, 3 (1.7%) resulted in death, 167 (97.1%) required hospitalization, and 1 (0.6%) were considered life-threatening.
Is Pericardial effusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 172 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Pericardial effusion?
TREPROSTINIL (584)
IBRUTINIB (467)
CYCLOPHOSPHAMIDE (458)
NIVOLUMAB (454)
METHOTREXATE (412)
MACITENTAN (407)
DASATINIB (388)
ADALIMUMAB (374)
AMBRISENTAN (371)
PEMBROLIZUMAB (362)
Which ROSUVASTATIN Alternatives Have Lower Pericardial effusion Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN